Submission Details
| 510(k) Number | K925493 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 02, 1992 |
| Decision Date | April 21, 1994 |
| Days to Decision | 535 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K925493 is an FDA 510(k) clearance for the BIOMERIEUX HEMOLAB THROMBICALCI-TEST, a Test, Thrombin Time (Class II — Special Controls, product code GJA), submitted by Biomerieux Vitek, Inc. (Hazelwood, US). The FDA issued a Cleared decision on April 21, 1994, 535 days after receiving the submission on November 2, 1992. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7875.
| 510(k) Number | K925493 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 02, 1992 |
| Decision Date | April 21, 1994 |
| Days to Decision | 535 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GJA — Test, Thrombin Time |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7875 |